Literature DB >> 8070435

Eradication of convalescent-phase Salmonella carriage in children with two oral doses of pefloxacin.

J Raymond1, F Moulin, J Badoual, D Gendrel.   

Abstract

Fifteen children (age range 1.5 months to 7.2 years), who were excluded from schools or nurseries due to asymptomatic convalescent-phase non-typhoidal Salmonella carriage, received two oral doses of pefloxacin (12 mg/kg on days 1 and 4) and were examined on days 10, 30, 45 and 60. Definitive eradication was observed in 13 patients, all of whom had initial low Salmonella counts in stools and were culture-negative by day 10. In the two patients who failed to respond, the same treatment was effective when repeated 4 and 6 months later respectively. No side-effects were observed. In six other children, considered as controls, eradication by day 10 was observed in only one case after administration of amoxicillin for eight days. Two oral doses of pefloxacin could be a useful and safe means for eliminating Salmonella carriage in young children.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8070435     DOI: 10.1007/bf01974606

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  6 in total

Review 1.  Quinolone antibiotics in the treatment of Salmonella infections.

Authors:  M O Asperilla; R A Smego; L K Scott
Journal:  Rev Infect Dis       Date:  1990 Sep-Oct

2.  Faecal excretion of ciprofloxacin after a single oral dose and its effect on faecal bacteria in healthy volunteers.

Authors:  S Pecquet; S Ravoire; A Andremont
Journal:  J Antimicrob Chemother       Date:  1990-07       Impact factor: 5.790

3.  Effect of antibiotic treatment on duration of excretion of Salmonella typhimurium by children.

Authors:  J M Dixon
Journal:  Br Med J       Date:  1965-12-04

Review 4.  A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella.

Authors:  D S Buchwald; M J Blaser
Journal:  Rev Infect Dis       Date:  1984 May-Jun

5.  Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin.

Authors:  U B Schaad; C Stoupis; J Wedgwood; H Tschaeppeler; P Vock
Journal:  Pediatr Infect Dis J       Date:  1991-10       Impact factor: 2.129

6.  Use of pefloxacin after failure of initial antibiotic treatment in children with severe salmonellosis.

Authors:  D Gendrel; J Raymond; M A Legall; M Bergeret; J Badoual
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-03       Impact factor: 3.267

  6 in total
  2 in total

Review 1.  Fluoroquinolones in paediatrics.

Authors:  D Gendrel; F Moulin
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Fluoroquinolones in paediatrics--1995.

Authors:  R Dagan
Journal:  Drugs       Date:  1995       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.